BioCentury
ARTICLE | Clinical News

Medidur fluocinolone acetonide intravitreal implant: Completed Phase III enrollment

October 10, 2016 7:00 AM UTC

pSivida completed enrollment of 150 patients in a double-blind, sham-controlled, Indian Phase III trial evaluating 0.18 mg intravitreal Medidur. The product uses the same micro-insert and corticostero...